| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |